Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K A Papp

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 27, 2024
Efficacy and safety of piclidenoson in plaque psoriasis: Results from a randomized phase 3 clinical trial (COMFORT-1)K A Papp, S Beyska-Rizova, M L Gantcheva, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 13, 2017
European S3-Guideline on the systemic treatment of psoriasis vulgaris - Update Apremilast and Secukinumab - EDF in cooperation with EADV and IPCA Nast, P I Spuls, G van der Kraaij, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 21, 2015
European S3-Guidelines on the systemic treatment of psoriasis vulgaris--Update 2015--Short version--EDF in cooperation with EADV and IPCA Nast, P Gisondi, A D Ormerod, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 27, 2024
Efficacy and safety of piclidenoson in plaque psoriasis: Results from a randomized phase 3 clinical trial (COMFORT-1)K A Papp, S Beyska-Rizova, M L Gantcheva, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 13, 2017
European S3-Guideline on the systemic treatment of psoriasis vulgaris - Update Apremilast and Secukinumab - EDF in cooperation with EADV and IPCA Nast, P I Spuls, G van der Kraaij, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 21, 2015
European S3-Guidelines on the systemic treatment of psoriasis vulgaris--Update 2015--Short version--EDF in cooperation with EADV and IPCA Nast, P Gisondi, A D Ormerod, et al.
Pageof 6